138 related articles for article (PubMed ID: 25227823)
1. Association between a polymorphism in miR-34b/c and susceptibility to cancer--a meta-analysis.
Lin Z; Chen L; Song M; Shi KQ; Tang KF
Asian Pac J Cancer Prev; 2014; 15(17):7251-5. PubMed ID: 25227823
[TBL] [Abstract][Full Text] [Related]
2. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.
Li X; Wang L; Yu J; Xu J; Du J
Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019
[TBL] [Abstract][Full Text] [Related]
3. Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data.
Yi DH; Wang BG; Zhong XP; Liu H; Liu YF
Tumour Biol; 2014 Dec; 35(12):11967-75. PubMed ID: 25201061
[TBL] [Abstract][Full Text] [Related]
4. Association between rs4938723 functional polymorphism in the promoter region of miR-34b/c gene and cancer risk.
Liu Q; Yang G; Song XL; Wang Z; Shi G
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):526-33. PubMed ID: 25475831
[TBL] [Abstract][Full Text] [Related]
5. MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis.
Ji TX; Zhi C; Guo XG; Zhou Q; Wang GQ; Chen B; Ma FF
Asian Pac J Cancer Prev; 2015; 16(14):6099-104. PubMed ID: 26320502
[TBL] [Abstract][Full Text] [Related]
6. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.
Tao T; Chen S; Xu B; Liu C; Wang Y; Huang Y; Chen M
Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659
[TBL] [Abstract][Full Text] [Related]
7. Association between miR-34b/c rs4938723 polymorphism and risk of cancer: An updated meta-analysis of 27 case-control studies.
Hashemi M; Moazeni-Roodi A; Bahari G; Taheri M; Ghavami S
J Cell Biochem; 2019 Mar; 120(3):3306-3314. PubMed ID: 30203457
[TBL] [Abstract][Full Text] [Related]
8. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
[TBL] [Abstract][Full Text] [Related]
9. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
10. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
[TBL] [Abstract][Full Text] [Related]
11. An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.
Li H; Diao S; Li J; Ma B; Yuan S
Oncotarget; 2017 Apr; 8(17):28888-28896. PubMed ID: 28415817
[TBL] [Abstract][Full Text] [Related]
12. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.
Zhu J; Yang L; You W; Cui X; Chen Y; Hu J; Liu W; Li S; Song X; Wei Y; Zhang W; Li F
Int J Clin Exp Pathol; 2015; 8(6):7332-40. PubMed ID: 26261633
[TBL] [Abstract][Full Text] [Related]
14. Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children.
Tong N; Chu H; Wang M; Xue Y; Du M; Lu L; Zhang H; Wang F; Fang Y; Li J; Wu D; Zhang Z; Sheng X
Leuk Lymphoma; 2016; 57(6):1436-41. PubMed ID: 26380954
[TBL] [Abstract][Full Text] [Related]
15. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
Xu B; Zhu Y; Tang Y; Zhang Z; Wen Q
Med Sci Monit; 2018 Oct; 24():7057-7071. PubMed ID: 30286050
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
[TBL] [Abstract][Full Text] [Related]
17. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
20. The interaction of miR-34b/c polymorphisms and negative life events increases susceptibility to major depressive disorder in Han Chinese population.
Xu C; Yang C; Zhang A; Xu Y; Li X; Liu Z; Liu S; Sun N; Zhang K
Neurosci Lett; 2017 Jun; 651():65-71. PubMed ID: 28461137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
